Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
EuromaidanRevolution's Profile
Displaying 1-20 of 20 result(s).
CYDY CytoDyn Inc
10/08/2024 12:17:02 PM
So I replied to a post (146965) enc (4)
CYDY CytoDyn Inc
10/08/2024 11:56:52 AM
https://investorshangout.com/post/
CYDY CytoDyn Inc
10/01/2024 10:40:48 AM
https://www.youtube.com/watch?v=NB (7)
CYDY CytoDyn Inc
09/30/2024 9:04:59 PM
https://www.youtube.com/watch?v=Qu (1)
CYDY CytoDyn Inc
09/30/2024 5:08:53 PM
Governor Abbott announced the Texas (5)
CYDY CytoDyn Inc
09/14/2024 5:03:41 PM
I used to fly over the St Helen sum (4)
CYDY CytoDyn Inc
08/27/2024 1:02:40 PM
May I call you Sean? Thank you, Sea (22)
CYDY CytoDyn Inc
08/26/2024 7:30:17 PM
In my prior military experience the (5)
CYDY CytoDyn Inc
08/26/2024 6:49:48 PM
And what do they say about Leronlim
CYDY CytoDyn Inc
08/26/2024 1:34:13 PM
Pfizer's(BP) worldwide disseminatio (8)
CYDY CytoDyn Inc
08/24/2024 11:14:54 PM
"Again, it's said they don't want c (2)
CYDY CytoDyn Inc
08/23/2024 3:05:39 PM
)
CYDY CytoDyn Inc
08/19/2024 11:33:24 AM
Apparently AI has concluded a "Like (2)
CYDY CytoDyn Inc
08/16/2024 2:34:44 PM
Sorry it took so long to answer. Ye (22)
CYDY CytoDyn Inc
08/14/2024 5:14:51 PM
Very well said, sir!
CYDY CytoDyn Inc
08/14/2024 4:37:05 PM
The story from history starts in En (3)
CYDY CytoDyn Inc
08/14/2024 4:10:43 PM
No. There is no comparison to what (4)
CYDY CytoDyn Inc
08/14/2024 4:06:48 PM
I have been promoting Delta 32 on m (1)
CYDY CytoDyn Inc
08/14/2024 3:12:36 PM
Dr. L and his team are choosing joi (14)
CYDY CytoDyn Inc
08/12/2024 12:30:17 PM
What investors might take note of i (3)

Recent Articles

  • BIGBEN INTERACTIVE Reports Strong Start to Fiscal Year 2025-26
  • Rexel's Second Quarter and First Half Performance Overview
  • Vastned Shares Strong Growth and Financial Stability in 2025
  • Hargreave Hale AIM VCT Insights: Q3 Performance Review
  • Mereo BioPharma Group plc Faces Scrutiny Over Investment Concerns
  • AMD Stock Sees Surge on AI Chip Pricing Adjustments
  • Unicycive Therapeutics Faces Legal Scrutiny from Investors
  • Understanding China's Economic Resilience Amidst Global Challenges
  • Investigation into Necessity Retail REIT: What Investors Should Know
  • Major Donation Fuels Breakthrough Research in Stuttering Treatment
  • Innovative System Designed to Manage Crawl Space Water Problems
  • Coco Robotics Integrates Autonomous Delivery with White Castle
  • Harin Shetty Joins West Monroe to Foster Innovation and Growth
  • Innovative Partnership Launches Rapidise with $4M Funding
  • Ekinops Reports Strong 2025 Results with Increased Margins
  • Sequana Medical Announces Key Shareholder Transparency Trends
  • TELUS and Welch's Form Innovative Partnership for Food Compliance
  • Centric Software Unveils Innovative Mobile PLM for Teams
  • Vicat H1 2025: Resilience Amid Economic Turmoil
  • Levine Leichtman Capital Partners Expands Portfolio with Shipley
  • Declining Trust in U.S. Food Safety: A Rising Concern Among Americans
  • Growth Outlook for the Asphalt Additives Market by 2031
  • Global Automotive Seals Market Forecast and Key Insights
  • Growth Projections for the Sprayed-in-Place Pipe Industry
  • Exploring the Future of the Aircraft Pumps Market Through 2034
  • Investors Alert: Class Action Lawsuit Against RxSight, Inc.
  • Optimism Surges for American Airlines Despite Earnings Concerns
  • Ransomware Threats Surge: Insights from Q2 2025 Analysis
  • Pomerantz Law Firm Looks Into Investor Claims Against Dow Inc.
  • Easterly ROCMuni Bond Fund Class Action Lawsuit Updates
  • Fiserv Inc. Faces Class Action as Investors Respond to Stock Decline
  • Geely Automobile Holdings Under Investigation for Fraud Claims
  • NACON Achieves Impressive €31.3 Million Sales in Q1 2025
  • Legal Investigation into MarineMax's Business Practices
  • ASM International Completes Significant Share Buyback Program
  • EssilorLuxottica's Impressive Q2 Growth and AI Innovations
  • The Growth Journey of Ascendis Pharma Over the Past Decade
  • Bolloré SE Challenges AMF Decision on Vivendi Buyout Offer
  • Replimune Group Faces Class Action Amid Stock Price Drop
  • UES Enhances Reach with Strategic Acquisition of GME Testing
  • Investigation into Dyne Therapeutics' Business Practices and Fraud
  • Investigation Insights on GSK plc and Investor Impact
  • ASM International Completes €150 Million Share Buyback Program
  • Investing Insights: The Future of Nutex Health Inc. Explained
  • Pomerantz Law Firm's Investigation into ZEEKR Technology Investors
  • Understanding Market Trends Through Tech Giants' Earnings
  • Rexel Unveils Comprehensive Financial Insights for H1 2025
  • Diving Into Graphic Packaging's Impressive 15-Year Growth
  • Tevogen.AI Celebrates U.S. AI Action Plan Advancements
  • CervoMed Announces Positive Progress in Dementia Treatment Study
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site